139 results on '"Eisenhofer, G."'
Search Results
2. Neuropeptide Hormone Receptor Expression in Human Adrenal Tumors and Cell Lines: Antiproliferative Effects of Peptide Analogues.
3. Pregnancy and phaeochromocytoma/paraganglioma: clinical clues affecting diagnosis and outcome – a systematic review
4. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
5. Principles of Catecholamine Biosynthesis, Metabolism and Release
6. Biochemical Diagnosis of Pheochromocytoma
7. Diagnostic Imaging of Pheochromocytoma
8. Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
9. Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease?
10. OC-0152: Glutamine metabolism as potential biomarker and target for prostate cancer radiosensitization
11. Adrenal medullary dysfunction as a feature of obesity
12. [PP.12.17] EVALUATION OF SELECTED PARAMETERS OF NEURO-HORMONAL ACTIVITY AND RETINAL AND INTRARENAL PERFUSION IN PATIENTS WITH POLYCYTHEMIA VERA
13. Steroid Hormone Production in Patients with Aldosterone Producing Adenomas
14. 7D.07
15. Prospective prediction of germ line mutations in patients with pheochromocytomas and paragangliomas according to biochemical profiles
16. Biochemical diagnosis of pheochromocytoma by measurements of overnight excretion levels of catecholamines and metabolites as a simplified alternative to 24-hour collections
17. Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells
18. Genotype-Specific Differences in the Tumor Metabolite Profile of Pheochromocytoma and Paraganglioma Using Untargeted and Targeted Metabolomics
19. Sympathoadrenal Medullary System and Stress
20. P01.03 * FUNCTIONAL CHARACTERISATION OF THE ISOCITRATE DEHYDROGENASE 1 (IDH 1) R132H MUTATION IN GLIOMAS
21. Impact of mineralocorticoid receptor blockade on vascular function in atherosclerotic mouse models under high-fat diet
22. Genetics and the Clinical Approach to Paragangliomas
23. 228: A novel animal model of phaeochromocytoma for preclinical therapy evaluation
24. Changes in morphology and function of adrenal cortex in mice fed a high-fat diet
25. Impaired blood glucose regulation during physical exercise in APS2 patients with combined Addison's disease and type 1 diabetes
26. Evaluation of a novel fluorescence-based animal model of pheochromocytoma for theragnostic investigations
27. Seasonal variation of plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma
28. Utility of LC-MS/MS based adrenal venous steroid profiling: Should cortisol remain the gold standard for selectivity and comparisons to aldosterone?
29. Measurements of plasma metanephrines by immunoassay versus LC-MS/MS for diagnosis of pheochromocytoma
30. Influence of a mineralocorticoid receptor blockade on vascular function in atherosclerotic mouse models under high-fat diet
31. Identification and stratification of pheochromocytomas/paragangliomas with SDHx mutations using the succinate to fumarate ratio
32. SDHB mutation testing in metastatic pheochromocytoma and paraganglioma: Is this required in patients with adrenaline-producing tumors?
33. Phäochromozytom: Diagnostik und Therapie
34. Die Diagnose des Phäochromozytoms und Paraganglioms
35. Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells
36. Utility of urinary free catecholamines and their O-methylated metabolites for diagnosis of pheochromocytoma in comparison to total urinary metanephrines
37. Plasma free versus deconjugated metanephrines for diagnosis of pheochromocytoma
38. Novel therapeutic strategies for the treatment of pheochromocytoma
39. Plasma metanephrine for assessing the selectivity of adrenal venous sampling
40. Rapid testing in adrenal venous sampling
41. Mortality Associated with Phaeochromocytoma
42. Die Diagnose des Phäochromozytoms und Paraganglioms
43. Metabolomic distinction of microvascular effects of lipoprotein apheresis – A pilot study
44. LAB-METABOLIC PATHWAYS
45. Pheochromocytoma and Paraganglioma: Recent Progress and New Vistas for Improved Patient Care
46. Genetic Screening for von Hippel-Lindau Gene Mutations in Non-syndromic Pheochromocytoma: Low Prevalence and False-positives or Misdiagnosis Indicate a Need for Caution
47. Endokrine Hypertonie - Neuigkeiten und jüngste Entwicklungen
48. Chromaffin cells: the peripheral brain
49. Neue Entwicklungen bei Nebennierenerkrankungen
50. Reference intervals of plasma catecholamines in newborns for diagnosis of Menkes disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.